Aggregation mechanisms of cystatins: A comparative study of monellin and oryzacystatin

Biochemistry

Volumn 49, Issue 13, 2010, Pages 2805-2810

  Esposito, Veronica ^a   Guglielmi, Fulvio ^b   Martin, Stephen R ^a   Pauwels, Kris ^a   Pastore, Annalisa ^a   Piccoli, Renata ^b,c   Temussi, Piero A ^a,b  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c NATIONAL INSTITUTE OF BIOSTRUCTURES AND BIOSYSTEMS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

A PLANTS; AGGREGATION MECHANISM; AMYLOID FIBERS; C-TERMINAL SEQUENCES; COMPARATIVE STUDIES; CYSTATINS; ENVIRONMENTAL CONDITIONS; MODEL SYSTEM; NON-NATIVE; PROTEIN AGGREGATION; PROTEIN MISFOLDING; SINGLE CHAINS; THREE-DIMENSIONAL ARCHITECTURE;

AGGREGATES; GLYCOPROTEINS; THREE DIMENSIONAL;

PROTEINS;

AMYLOID PROTEIN; CYSTATIN; CYSTATIN MNEI; MONELLIN; ORYZACYSTATIN; THIOFLAVINE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CIRCULAR DICHROISM; CONTROLLED STUDY; ELECTRON MICROSCOPY; FLUORESCENCE ANALYSIS; GEL FILTRATION; GEL PERMEATION CHROMATOGRAPHY; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN STRUCTURE; THERMODYNAMICS; THERMOSTABILITY; TRANSMISSION ELECTRON MICROSCOPY;

AMINO ACID SEQUENCE; AMYLOID; CYSTATINS; ORYZA SATIVA; PLANT PROTEINS; PROTEIN CONFORMATION; PROTEIN DENATURATION; PROTEIN FOLDING; PROTEIN MULTIMERIZATION;

EID: 77950402224     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi902039s     Document Type: Article

References (37)

1. Temussi, P.A., Masino, L., and Pastore, A. (2003) From Alzheimer to Huntington, why is a structural understanding so difficult? EMRO .J. 22, 355-361. (Pubitemid 36193581)
2. Ross, C. A., and Poirier, M. A. (2005) Opinion, What is the role of protein aggregation in neurodegeneration? Nat. Rev. Mol. Cell. Biol. 6, 891-898. (Pubitemid 41568738)
3. Ross, C. A., and Poirier, M. A. (2004) Protein aggregation and neurodegenerative disease. Nat. Med. 10 (Suppl.), S10-S17.
4. Caughey, B., and Lansbury, P. T. (2003) Protofibrils pores fibrils and neurodegeneration, separating the responsible protein aggregates from the innocent bystanders. Annu. Rev. Neurosci. 26, 267-298. (Pubitemid 37064935)
5. Hardy, J., and Selkoe, D. J. (2002) The amyloid hypothesis of Alzheimer's disease, progress and problems on the road to therapeutics. Science 297, 353-356.
6. Bennett, M. J., Sawaya, M. R., and Eisenberg, D. (2006) Deposition diseases and 3D domain swapping. Structure 14, 811-824.
7. Gudmundsson, G., Hallgrímsson, J., Jónasson, T. A., and Bjarnason, O. (1972) Hereditary cerebral haemorrhage with amyloidosis. Brain 95, 387-404.
8. Abrahamson,M.,andGrubb,A.(1994) IncreasedbodytemperatureacceleratesaggregationoftheLeu-68-GlnmutantcystatinC, theamyloid-formingproteininhereditarycystatinCamyloidangiopathy.Proc.Natl.Acad. Sc.U.S.A-91,1416-1420.(Pubitemid24059022)
9. Barrett, A. J. (1986) The cystatins: a diverse superfamily of cysteine peptidase inhibitors. Biomed. Biochim. Acta 45, 1363-1374.
10. Brown, W. M., and Dziegielewska, K. M. (1997) Friends and relations of the cystatin superfamily-new members and their evolution. Protein Sci. 6, 5-12.
11. Grubb, A. (2000) Cystatin C-properties and use as diagnostic marker. Adv. Clin. Chem. 35, 63-99.
12. Yamada, M. (2000) Cerebral amyloid angiopathy, an overview. Neuropathology 20, 8-22.
13. Janowski, R., Kozak, M., Jankowska, E., Grzonka, Z., Grubb, A., Abrahamson, M., and Jaskolski, M. (2001) Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping. Nat. Struct. Biol. 8, 316-320. (Pubitemid 32275015)
14. Bennett,M.J.,Choe,S.,andEisenberg,D.(1994) Refinedstructureofdimericdiphtheriatoxinat20Åresolution.ProteinSci.3, 1444-1463.(Pubitemid24314464)
15. Konno, T. (2001) Multistep nucleus formation and a separate subunit contribution of the amyloidogenesis of heat-denatured monellin. Prntein Sci. 10, 2093-2101.
16. Kim, S. H, Kang, C.-H, Kim, R., Cho, J. M., Lee, Y.-B., and. Lee, T.-K. (1989) Redesigning a sweet protein, increased stability and renaturability. Protein. Eng. 2, 571-575.
17. Jenko, S., Skarabot, M., Kenig, M., Guncar, G., Musevic, I., Turk, D., and Zerovnik, E. (2004) Different propensity to form amyloid fibrils by two homologous proteins-human stefins A and B: searching for an explanation. Proteins 55, 417-425. (Pubitemid 38437497)
18. Spadaccini, R., Crescenzi, O., Tancredi, T., De Casamassimi, N., Saviano, G., Scognamiglio, R., Di Donato, A., and Temussi, P. A. (2001) Solution structure of a sweet protein, nmr study of mnei, a single chain monellin. J. Mol. Biol. 305, 505-514. (Pubitemid 33032857)
19. Spadaccini, R., Trabucco, F., Saviano, G., Picone, D., Crescenzi, O., Tancredi, T., and Temussi, P. A. (2003) The mechanism of interaction of sweet proteins with the T1R2-T1R3 receptor, evidence from the solution structure of G16A-MNEI. J. Mol. Biol. 328, 683-692. (Pubitemid 36438581)
20. Morris, J. A., Martenson, R., Deibler, G., and Cagan, R. H. (1973) Characterization of monellin, a protein that tastes sweet. J. Biol. Chem. 248, 534-539.
21. Esposito, V., Gallucci, R., Picone, D., Tancredi, T., and. Temussi, P. A. (2006) The importance of electrostatic potential in the interaction of sweet proteins with the sweet taste receptor. J. Mol. Biol. 360, 448-456.
22. Tancredi, T., Iijima, H., Saviano, G., Amodeo, P., and Temussi, P. A. (1992) Structural determination of the active site of a sweet protein: a Greek capital letter eta with tonos NMR investigation of pMNEI. FEBS Lett. 310, 27-30.
23. Konno, T., Murata, K., and Nagayama, K. (1999) Amyloid-like aggregates of a plant protein, a case of a sweet-tasting protein monellin. FEBS Lett. 454, 122-126. (Pubitemid 29296937)
24. Becktel, W. J., and Schellman, J. A. (1987) Protein stability curves. Biopolymers 26, 1859-1877.
25. Masino,L.,Martin,S.R.,andBayley,P.M.(2000) Ligandbindingandthermodynamicstabilityofamulti-domainproteincalmodulin.Protein. Sci.9,1519-1529.(Pubitemid30659190)
26. Myers, J. K., Pace, C. N., and Scholtz, J. M. (1995) Denaturant m values and heat capacity changes: relation to changes in accessible surface areas of protein unfolding. Protein Sci. 4, 2138-2148.
27. Levine, H. (1993) Thioflavine T interaction with synthetic Alzheimer's disease P3-amyloid peptides, detection of amyloid aggregation in solution. Protein Sci. 2, 404-410.
28. Naiki, H., Higuchi, K., Hosokawa, M., and. Takeda, T. (1989) Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye thioflavin T1. Anal. Biochem. 177, 244-249.
29. Temussi, P. A. (2002) Why are sweet proteins sweet? Interaction of brazzein, monellin and thaumatin with the T1R2-T1R3 receptor. FEBS Lett. 526, 1-4.
30. Thompson, J. D., Gibson, T. J., Plewniak, F., Jeanmougin, F., and Higgins, D. G. (1997) The CLUSTAL-X windows interface, flexible strategies for multiple sequence alignment aided by quality analysis tools.Nucleic Acids. Res. 24, 4876-4882. (Pubitemid 28022245)
31. Abrahamson, M., Ritonja, A., Brown, M. A., Grubb, A., Machleidt, W., and Barrett, A. J. (1987) Identification of the probable inhibitory reactive sites of the cysteine proteinase inhibitors human cystatin. C and chicken cystatin. J. Biol. Chem- 262, 9688-9694.
32. Nagata, K., Kudo, N., Abe, K., Arai, S., and Tanokura, M. (2000) Three-dimensional solution structure of oryzacystatin-I, a cysteine proteinase inhibitor of the rice Oryza sativa L. japonica. Biochemistry 39, 14753-14760.
33. Kenig, M., Jenko-Kokalj, S., Tusek-Znidaric, M., Pompe-Novak, M., Guncar, G., Turk, D., Waltho, J. P., Staniforth, R. A., Avbelj, F., and Zerovnik, E. (2006) Folding and amyloid-fibril formation for a series of human stefins' chimeras: any correlation? Proteins 62, 918-927. (Pubitemid 43364156)
34. Dobson, C. M. (2001) The structural basis of protein folding and its links with human disease. Philos. Trans. R. Soc. London. Ser. B 356, 133-145.
35. Nilsson, M., Wang, X., Rodziewicz-Motowidlo, S., Janowski, R., Lindström, V., Onnerfjord, P., Westermark, G, Grzonka, Z., Jaskolski, M., and Grubb, A. (2004) Prevention of domain swapping inhibits dimerization and amyloid fibril formation of cystatin C: use of engineered disulfide bridges, antibodies, and carboxymethylpapain to stabilize the monomelic form of cystatin C. J. Biol. Chem. 279, 24236-32445 (Pubitemid 38725285)
36. Janowski, R., Abrahamson, M., Grubb, A., and Jaskolski, M. (2004) Domain swapping in N-truncated human cvstatin C. J. Mol. Biol. 341, 151-160. (Pubitemid 39090641)
37. Koradi, R., Billeter, M., and Wüthrich, K. (1996) MOLMOL: a program for display and analysis of macromolecular structure. J. MoI. Graphics 14, 51-55. (Pubitemid 26152976)